{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T06:59:08Z","timestamp":1782197948337,"version":"3.54.5"},"reference-count":24,"publisher":"Elsevier BV","issue":"40","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T00:00:00Z","timestamp":1503446400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.vaccine.2017.08.042","type":"journal-article","created":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T02:46:39Z","timestamp":1504147599000},"page":"5325-5330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Results on exposure during pregnancy from a pregnancy registry for AS04-HPV-16\/18 vaccine"],"prefix":"10.1016","volume":"35","author":[{"given":"Marta","family":"L\u00f3pez-Fauqued","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Zima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Genalin","family":"Angelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens-Ulrich","family":"Stegmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.08.042_b0005","doi-asserted-by":"crossref","first-page":"332","DOI":"10.4161\/hv.5.5.7211","article-title":"Safety of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine for cervical cancer prevention: a pooled analysis of 11 clinical trials","volume":"5","author":"Descamps","year":"2009","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2017.08.042_b0010","unstructured":"Public Health England. Department of Health. Annual HPV vaccine coverage in England in 2010\/2011. 2012. http:\/\/media.dh.gov.uk\/network\/211\/files\/2012\/03\/120319_HPV_UptakeReport2010-11-revised_acc.pdf [accessed December 1, 2013]."},{"key":"10.1016\/j.vaccine.2017.08.042_b0015","doi-asserted-by":"crossref","first-page":"6884","DOI":"10.1016\/j.vaccine.2015.07.024","article-title":"Risk of spontaneous abortion and other pregnancy outcomes in 15\u201325 year old women exposed to human papillomavirus-16\/18 AS04-adjuvanted vaccine in the United Kingdom","volume":"33","author":"Baril","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.08.042_b0020","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/pds.3554","article-title":"Pooled analysis of large and long-term safety data from the human papillomavirus-16\/18-AS04-adjuvanted vaccine clinical trial programme","volume":"23","author":"Angelo","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2017.08.042_b0025","unstructured":"European Medicines Agency (Committee for Medicinal Products for Human Use). Guideline on the exposure to medicinal products during pregnancy: need for post-authorisation data. EMEa\/CHMP\/313666\/2005. London: EMEA; 2005."},{"key":"10.1016\/j.vaccine.2017.08.042_b0030","unstructured":"CDC. Birth Defects and genetic diseases branch 6-digit code for reportable congenital anomalies; 1998. http:\/\/www.cdc.gov\/ncbddd\/birthdefects\/documents\/macdpcode0807.pdf [accessed July 11, 2016]."},{"key":"10.1016\/j.vaccine.2017.08.042_b0035","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/bdra.10111","article-title":"The Metropolitan Atlanta Congenital Defects Program: 35 years of birth defects surveillance at the Centers for Disease Control and Prevention","volume":"67","author":"Correa-Villase\u00f1or","year":"2003","journal-title":"Birth Defects Res Part A Clin Mol Teratol"},{"key":"10.1016\/j.vaccine.2017.08.042_b0040","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/tera.1071","article-title":"Postmarketing surveillance for human teratogenicity: a model approach","volume":"64","author":"Chambers","year":"2001","journal-title":"Teratology"},{"key":"10.1016\/j.vaccine.2017.08.042_b0045","unstructured":"U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER) Reviewer Guidance Evaluating the Risks of Drug Exposure in Human Pregnancies 2005."},{"key":"10.1016\/j.vaccine.2017.08.042_b0050","unstructured":"European Centre for Disease Prevention and Control (ECDC)-Health Comunication Unit- Eurosurveillance editorial. The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey 2010. http:\/\/www.eurosurveillance.org\/viewarticle.aspx?ArticleId=19730 (accessed September 7, 2012)."},{"key":"10.1016\/j.vaccine.2017.08.042_b0055","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/pds.3593","article-title":"Post-licensure safety surveillance for AS04-adjuvanted Human Papillomavirus vaccine: more than 4 years of experience","volume":"23","author":"Angelo","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2017.08.042_b0060","unstructured":"GlaxoSmithKline Pregnancy Registries 2016. http:\/\/pregnancyregistry.gsk.com\/ [accessed July 11, 2016]."},{"key":"10.1016\/j.vaccine.2017.08.042_b0065","unstructured":"Public Health England. Vaccination in pregnancy (VIP) - Detailed guidance - GOV.UK 2010. https:\/\/www.gov.uk\/guidance\/vaccination-in-pregnancy-vip [accessed June 19, 2016]."},{"key":"10.1016\/j.vaccine.2017.08.042_b0070","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/oxfordjournals.aje.a009747","article-title":"Estimates of the annual number of clinically recognized pregnancies in the United States, 1981\u20131991","volume":"149","author":"Saraiya","year":"1999","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2017.08.042_b0075","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1177\/014107680109400607","article-title":"Design or accident? The natural history of teenage pregnancy","volume":"94","author":"Seamark","year":"2001","journal-title":"J R Soc Med"},{"issue":"1\u201325","key":"10.1016\/j.vaccine.2017.08.042_b0080","first-page":"28","article-title":"Estimated pregnancy rates by outcome for the United States, 1990\u20132004","volume":"56","author":"Ventura","year":"2008","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.vaccine.2017.08.042_b0085","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/pds.1862","article-title":"The identification of pregnancies within the general practice research database","volume":"19","author":"Devine","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2017.08.042_b0090","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0031-3955(03)00029-4","article-title":"Ankyloglossia: does it matter?","volume":"50","author":"Lalakea","year":"2003","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.vaccine.2017.08.042_b0095","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1542\/peds.100.5.831","article-title":"Hypospadias trends in two US surveillance systems","volume":"100","author":"Paulozzi","year":"1997","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2017.08.042_b0100","unstructured":"Koyfman A, Long B. Pilonidal Cyst and Sinus: Background, Pathophysiology, Epidemiology 2016."},{"key":"10.1016\/j.vaccine.2017.08.042_b0105","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/978-90-481-9485-8_20","article-title":"The prevalence of congenital anomalies in Europe","volume":"686","author":"Dolk","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.vaccine.2017.08.042_b0110","first-page":"265","article-title":"Medical genetics: 1. Clinical teratology in the age of genomics","volume":"167","author":"Polifka","year":"2002","journal-title":"CMAJ"},{"key":"10.1016\/j.vaccine.2017.08.042_b0115","doi-asserted-by":"crossref","first-page":"100","DOI":"10.7150\/ijms.2.100","article-title":"Risk and benefit of drug use during pregnancy","volume":"2","author":"B\u00e1nhidy","year":"2005","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.vaccine.2017.08.042_b0120","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1016\/j.vaccine.2015.04.014","article-title":"Final report on exposure during pregnancy from a pregnancy registry for quadrivalent human papillomavirus vaccine","volume":"33","author":"Goss","year":"2015","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17311301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17311301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T07:28:29Z","timestamp":1536046109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17311301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":24,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0264410X17311301"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.08.042","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Results on exposure during pregnancy from a pregnancy registry for AS04-HPV-16\/18 vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.08.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 GlaxoSmithKline SA. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}